Related Experiment Video
Updated: Mar 3, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
A Comprehensive Review of the Association between Sarcopenia and COPD
Tănase Andreea Mădălina1, Florentina Gherghiceanu1, Beatrice Mahler1,2
1"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Chronic Obstructive Pulmonary Disease (COPD) is linked to sarcopenia, a muscle-wasting condition. This review examines risk factors influencing sarcopenia prevalence and measurement in COPD patients.
Area of Science:
- Pulmonology
- Geriatrics
- Muscle Physiology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a growing global health issue, ranked as the fourth leading cause of mortality.
- COPD presents complex pulmonary and extrapulmonary manifestations.
- Sarcopenia, characterized by decreased muscle mass and function, frequently co-occurs with COPD due to shared risk factors.
Purpose of the Study:
- To identify key risk factors contributing to variable sarcopenia outcomes in COPD.
- To analyze the impact of population characteristics, sarcopenia definition criteria, and measurement methods on reported prevalence.
- To provide a comprehensive overview of sarcopenia in COPD for better understanding and management.
Main Methods:
- Systematic literature review focusing on studies investigating sarcopenia in COPD patients.
- Analysis of methodologies used for muscle mass assessment (e.g., MRI, DXA, BIA, CT, biopsy).
- Evaluation of criteria used to define sarcopenia and assessment of muscle strength and physical performance.
Main Results:
- Prevalence rates of sarcopenia in COPD vary significantly across studies.
- Discrepancies in outcomes are linked to differences in study populations, diagnostic criteria, and measurement techniques.
- Identified risk factors include disease severity, inflammation, and nutritional status.
Conclusions:
- Standardized definitions and consistent measurement methods are crucial for accurate sarcopenia prevalence estimation in COPD.
- Understanding the contributing risk factors can guide targeted interventions.
- Further research is needed to optimize diagnostic and therapeutic strategies for sarcopenia in COPD patients.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction

